Cigna Corp
NYSE:CI

Watchlist Manager
Cigna Corp Logo
Cigna Corp
NYSE:CI
Watchlist
Price: 281.58 USD 0.54% Market Closed
Market Cap: 78.3B USD
Have any thoughts about
Cigna Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one CI stock under the Base Case scenario is 723.95 USD. Compared to the current market price of 281.58 USD, Cigna Corp is Undervalued by 61%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CI Relative Value
Base Case
723.95 USD
Undervaluation 61%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.3
P/S
P/S
Price to Sales
0.3
vs History
98
vs Industry
80
Median 3Y
0.5
Median 5Y
0.5
Industry
2.3
Forward
0.3
More Details
25.9
P/E
P/E
Price to Earnings
25.9
vs History
11
vs Industry
21
Median 3Y
14.9
Median 5Y
14
Industry
23.1
Forward
9.6
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
31
vs Industry
38
Median 3Y
1.9
Median 5Y
1.7
Industry
2.2
More Details
N/A
Price/Premiums
Price/Premiums
Price to Premiums
N/A
vs History
vs Industry
57
Median 3Y
0
Median 5Y
0
Industry
0.6
More Details

Multiples Across Competitors

CI Competitors Multiples
Cigna Corp Competitors

All Multiples
P/S
P/E
P/B
All Countries
All Countries
Close
Market Cap P/S P/E P/B
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 1.9
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 1.9
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 0.8
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 1.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 1
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 2.4
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 2.5
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 0.9
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 33.2
AU
Sonic Healthcare Ltd
ASX:SHL
13.1B AUD 1.5 25.6 1.7
P/E Multiple
Earnings Growth P/E to Growth
US
Cigna Corp
NYSE:CI
Average P/E: 26.8
25.9
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.9
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius Medical Care AG
XMUN:FME
48.1
127%
0.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.5
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3
AU
Sonic Healthcare Ltd
ASX:SHL
25.6
37%
0.7

See Also

Summary
CI intrinsic value, competitors valuation, and company profile.
DCF Valuation
CI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CI stock valuation using valuation multiples.
Wall Street Estimates
CI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.